AI is now one of the key drivers of innovation in oncology, with tangible benefits for diagnosis, treatment and data management.
This transformation presents new opportunities, but also clinical and organisational challenges.
The heads of oncology departments at major Italian hospitals discuss their experiences, the potential and the challenges of using AI for assisted diagnosis, personalised medicine and predictive analytics.
Carlo Buonamico
AI and neurological oncology – applications to glioblastoma
The Breastscan project
The experience of the IRCCS Policlinico di S. Orsola
CONCLUSIONS AND CASE HISTORY
MODERATE THE SESSION
Carlo Buonamico, professional journalist specializing in innovation, health, healthcare, and pharmaceuticals.
